Biotech

All Articles

3 biotechs attempt to trump the summer season warmth through shedding workers

.As biotechs try to switch a new webpage in August, at the very least three business have actually l...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Pro venture capital company venBio has elevated another half a billion bucks to acquire biotechs de...

Otsuka spends $800M for Jnana and also its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually gotten Boston-based Jnana Therapeutics for $800 million so the E...

FibroGen lays off 75% people team as resource flunks 2 additional trials

.FibroGen is significantly reorganizing its service, giving up 75% of its own USA personnel and ceas...

Tracon wane weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has actually determined to relax functions full weeks after an injectable in...

Ideaya bags choice on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on failed epilepsy medication, touts FDA operate

.Our team presently know that Takeda is actually wanting to discover a road to the FDA for epilepsy ...

VBI Vaccines apply for bankruptcy, finds asset purchase

.Immunology biotech VBI Vaccinations is actually diverting dangerously close to the point of no retu...

Celldex anti-cKIT antitoxin lessen hives in another phase 2 research

.It's hard to muscle in on a room as very competitive as immunology, yet Celldex Therapies strongly ...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics and a preclinical immune s...